GlassScriptPhysician profile
Jamison M King
NPI 1306296397
$2,398.30
in general payments reported to CMS, 2019-2025
24 companies · $460 in 2025
The $460 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $259 · 2022: $949 · 2023: $274 · 2024: $456 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,190.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $379.97 | 2021-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2, Cardioroot |
| Abbott Laboratories | $288.85 | 2023-2025 | Navitor, Amplatzer, Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $278.29 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $211.78 | 2022-2024 | Lifevest |
| Abiomed | $203.37 | 2022-2025 | |
| Atricure, INC. | $143.55 | 2023-2024 | |
| Lsi Solutions INC | $136.70 | 2021-2022 | |
| Baxter Healthcare | $136.42 | 2021-2022 | |
| Arthrex, INC. | $106.45 | 2025 | |
| Ethicon US, LLC | $80.83 | 2022 | |
| Potrero Medical, INC. | $51.08 | 2022 | |
| La Jolla Pharmaceutical Company | $50.17 | 2023-2025 | Giapreza |
| Kci USA, INC. | $47.61 | 2022-2023 | Prevena |
| Corcym INC | $45.14 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $42.33 | 2023 | Tagrisso |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clearflow INC. | $32.10 | 2023 | Pleuraflow System With Flowglide |
| Haemonetics Corporation | $26.62 | 2025 | Teg6s Hemostasis System |
| Sanara Medtech INC. | $23.89 | 2022 | |
| Solventum Corporation | $23.83 | 2024 | Prevena |
| Stryker Corporation | $23.66 | 2024 | Na |
| Depuy Synthes Sales INC. | $21.80 | 2021 | |
| Angiodynamics, INC. | $16.90 | 2021 | |
| Hemosonics LLC | $13.64 | 2021 | |
| Terumo Medical Corporation | $13.32 | 2023 | Azur Cx Detachable |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamison King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.